EUVIMEDEUVIMED entdecken
Crossref

Orally Administrated Glutamate Restored EAAT1 and 3 Expression Levels Suppressed in 5-Fluorouracil-damaged Intestinal Epithelial Cells

Shizuka Jonan, Mai Haneda, Kikuko Amagase

Anticancer Research · 2024

DOI: 10.21873/anticanres.16909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Shizuka Jonan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology & Pharmacotherapeutics, Graduate School of Pharmaceutical Sciences, Ritsumeikan University, Shiga, Japan. Hauptthemen laut MEDLINE: Fluorouracil, Mucositis. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: 5-Fluorouracil (5-FU) treatment induces intestinal mucositis, with diarrhea as the primary symptom. Mucositis significantly reduces patients' quality of life (QOL). Amino acids such as glutamate are beneficial for treating gastrointestinal disorders; however, the underlying mechanism remains unclear. Therefore, this study aimed to clarify the role of excitatory amino acid transporters (EAATs) in 5-FU-induced intestinal injury. MATERIALS AND METHODS: The rat intestinal epithelial cell line (IEC-6) was used to evaluate whether the EAAT inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid (L-trans-PDC) affects 5-FU-induced cytotoxicity. Mice with 5-FU-induced mucositis were used to determine the effects of glutamate on EAATs expression levels. RESULTS: Treatment with L-trans-PDC suppressed IEC-6 cell growth. It also exacerbated the 5-FU-induced cell growth suppression and increased inflammatory cytokine expression. In addition, mice treated with 5-FU+Glutamate showed higher EAAT1,3 expression than 5-FU only-treated mice. CONCLUSION: Decreased EAAT levels worsen intestinal cell damage caused by 5-FU, suppress cell growth, and induce inflammation. This study contributes to the understanding EAAT and its relationship with intestinal mucositis, which can aid in the development of novel preventive strategies for cancer chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluorouracilMucositisRatsHumansMiceAnimalsQuality of LifeGlutamic AcidIntestinal MucosaApoptosisEpithelial Cells

Stichwörter der Autor:innen

5-fluorouracilExcitatory amino acid transporters (EAATs)anti-cancer drugcytotoxicityintestinal epithelial cells

Substanzen

FluorouracilGlutamic Acid

Autor:innen und Institutionen

  • Laboratory of Pharmacology & Pharmacotherapeutics, Graduate School of Pharmaceutical Sciences, Ritsumeikan University, Shiga, Japan.
  • Laboratory of Pharmacology & Pharmacotherapeutics, Graduate School of Pharmaceutical Sciences, Ritsumeikan University, Shiga, Japan amagase@fc.ritsumei.ac.jp.

Zitieren

APA

Jonan, S., Haneda, M., & Amagase, K. (2024). Orally Administrated Glutamate Restored EAAT1 and 3 Expression Levels Suppressed in 5-Fluorouracil-damaged Intestinal Epithelial Cells. Anticancer Research. https://doi.org/10.21873/anticanres.16909

Vancouver

Jonan S, Haneda M, Amagase K. Orally Administrated Glutamate Restored EAAT1 and 3 Expression Levels Suppressed in 5-Fluorouracil-damaged Intestinal Epithelial Cells. Anticancer Research. 2024. doi:10.21873/anticanres.16909

BibTeX
@article{Jonan2024,
  author = {Jonan, Shizuka and Haneda, Mai and Amagase, Kikuko},
  title = {Orally Administrated Glutamate Restored EAAT1 and 3 Expression Levels Suppressed in 5-Fluorouracil-damaged Intestinal Epithelial Cells},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.16909}
}
Kostenlos starten →